12 Health Care Stocks Moving In Monday's After-Market Session
Olema Pharmaceuticals Inc OLMA
$11.45
▼ -3.13%
($-0.37)
🔥 High Short Interest
🎢 High Beta
🗓️ Earnings Next Week
Open
$11.77
Prev Close
$11.82
Day Range
$11.37 – $11.87
52W Range
$4.47 – $36.26
Market Cap
$1.00B
Beta
1.99
EPS (TTM)
$-2.03
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-11-19 |
| Shares Out. | 87,350,000 |
| Website | olema.com/ ↗ |
| Phone | 13026587581 |
| Employees | 137 |
| Net Income | -$53.1M |
| Total Assets | $530.6M |
| Total Liabilities | $50.2M |
| Equity | $480.5M |
About Olema Pharmaceuticals Inc
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Olema Pharmaceuticals Inc is a publicly traded company under the ticker symbol OLMA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-07-01)